Company Short-Term Debts: Microbot Medical Inc. (MBOT)

Microbot Medical, Inc (MBOT) - corporate logo

Microbot Medical Inc. (MBOT) is facing significant pressure due to potential cash gaps and uncertainty regarding FDA clearance for the Liberty system. This chart on GURU.Markets shows that the asset value stands at 0.00. Meanwhile, the company is expanding the minimally invasive intervention market by developing compact robots for surgeons, which substantially reduces the invasiveness of clinical procedures.

MBOT (Microbot Medical) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Summary analytical data breakdowns for Microbot Medical, Inc (MBOT)

- price and consensus price forecast:
Stock Price Microbot Medical|MBOT - Analyst Median Target
- market capitalization data:
Market Capitalization Microbot Medical Inc.|MBOT - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Microbot Medical|MBOT - Book Capitalization|Market Value to Book Value Ratio microbotmedical.com|MBOT - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Microbot Medical Inc.|MBOT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Microbot Medical Inc.|MBOT - Company Total Debt Obligations|Debt to Book Capitalization Ratio Microbot Medical Inc.|MBOT - Company Long-Term Indebtedness|Company Short-Term Debt Microbot Medical
Fundamental company valuation:Microbot Medical Inc.
Signature product of Microbot Medical, Inc

Professional managers utilize fundamental filters to assess an issuer's financial stability. This metric aggregates all credit obligations maturing within one year, reflecting current liquidity. For Microbot Medical Inc. (MBOT), such expenses are frequently linked to technological development within the robotic surgery sector. It is critical for investors to distinguish operational expenditures from a systemic crisis. The trend in short-term financial debt confirms the company's ability to maintain a high level of confidence among clinicians.

Competitor analysis for Microbot Medical Inc.

Company Short-Term Debts ISRG (Intuitive)|DHR - Short-Term Debt Volume|BDX (Becton, Dickinson and Company) - Company Short-Term Debts|STERIS Group (STE) - Company Current Liabilities|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts BAX|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt Stevanato Group SpA STVN|Company Current Liabilities Teleflex Inc|Company Short-Term Loans and Borrowings Merit Medical Corp MMSI|Company Short-Term Debts NVST (Envista Holdings)|ICUI: Short-Term Debt Volume|Company Short-Term Debt Dentsply Sirona|LMAT (LeMaitre Vascular Inc) - Company Short-Term Indebtedness|ATRC: Company Short-Term Debt|Short-Term Debt Volume STAAR Surgical Co (STAA)|Company Current Liabilities ChromaDex|Amount of Current Liabilities ZIMV (zimvie.com)|Company Short-Term Debt AngioDynamics|CERS - Company Short-Term Loans and Borrowings|Alpha Teknova Inc - Company Current Liabilities|MGRM: Company Short-Term Debts|STSS (sharpstechnology.com) - Company Short-Term Debt|InfuSystem Holdings, Inc. (INFU) - Company Current Liabilities|Company Short-Term Debts UTMD (Utah Medical Products, Inc.)|Short-Term Debt KRMD|Company Short-Term Debt Nyxoah, S.A. NYXH|Company Short-Term Indebtedness Pro-Dex Inc. PDEX|Company Current Liabilities Zentek Ltd. (ZTEK)|elutia.com - Amount of Current Liabilities|Company Short-Term Debt MLSS (Milestone Scientific Inc.)|NXGL: Short-Term Debt Volume|RVP (retractable.com) - Company Short-Term Debt|Harvard Bioscience Inc. (HBIO) - Company Current Liabilities|FEMY: Company Short-Term Debts|Short-Term Debt Volume Meihua Medical|Company Short-Term Debts POAI (Predictive Oncology)|Company Current Liabilities CJMB (callanjmb.com)|Company Short-Term Debt Atrion Corp|NeuroMetrix Corporation - Company Short-Term Loans and Borrowings